Food News and Research

RSS

Alkermes' phase 3 trial of naltrexone XR-NTX meets primary endpoint

Alkermes, Inc. today announced positive preliminary results from a phase 3 clinical trial of naltrexone for extended-release injectable suspension (XR-NTX) for the treatment of opioid dependence. The six-month phase 3 study met its primary efficacy endpoint and data showed that patients treated once-monthly with XR-NTX demonstrated statistically significant higher rates of clean (opioid-free) urine screens, compared to patients treated with placebo, as measured by the cumulative distribution of clean urine screens (p<0.0002).

16 Nov 2009

Sunlight Saunas renamed as Sunlighten

After a thorough, long-term strategic brand-building process, Sunlighten(TM) has been chosen as the new name for health & wellness leader Sunlight Saunas(TM). Under the same ownership and with a renewed sense of corporate mission, Sunlighten has plans for a host of cutting-edge wellness products over the coming years, including advances in its line of long-celebrated infrared saunas.

16 Nov 2009

FDA issues a Complete Response Letter for Human Genome Sciences' raxibacumab BLA

Human Genome Sciences, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) relating to the Company’s Biologics License Application (BLA) requesting the approval of raxibacumab for use in the treatment of inhalational anthrax. The FDA issues Complete Response Letters to request additional information needed to complete the review of a BLA.

16 Nov 2009

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.

16 Nov 2009

A.P. Pharma announces financial results for its third quarter ended September 30, 2009

A.P. Pharma, Inc., a specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2009.

16 Nov 2009

Fetal exposure to phthalates has the potential to alter masculine brain development: Study

A study of 145 preschool children reports, for the first time, that when the concentrations of two common phthalates in mothers' prenatal urine are elevated their sons are less likely to play with male-typical toys and games, such as trucks and play fighting.

16 Nov 2009

FDA files for permanent injunction against seafood processor Haifa Smoked Fish

The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, has filed a complaint for permanent injunction against seafood processor Haifa Smoked Fish Inc. of Jamaica, N.Y., and two of its top officers for violations of the Federal Food, Drug and Cosmetic Act.

16 Nov 2009

Ginger effective in treating post-chemo nausea in cancer patients

Reed's, Inc., maker of the top-selling sodas in natural food stores nationwide, announced today that it will be exhibiting at the Chemotherapy Foundation Symposium XXVII New Perspectives in Oncology Practice Seminar, Saturday November 14th, at the Marriott Marquis in New York, NY.

16 Nov 2009

FDA provides marketing clearance for the Platelet PGD Test System

The U.S. Food and Drug Administration today cleared for marketing the Platelet PGD Test System, the first rapid test for the detection of bacterial contamination in pooled platelets derived from whole blood.

16 Nov 2009

Potential success of U.N. World Food Summit questioned

Next week's World Food Summit in Rome "is not likely to make more than token headway in the fight against hunger, with leaders merely pledging to boost aid to poor countries but setting no targets or deadlines for action," Reuters/New York Times reports.

16 Nov 2009

Patent number for Microfluidic Valve Mechanism received

Microfluidic Systems, a privately-held company, announced today that they received patent number 7,607,641, entitled "Microfluidic Valve Mechanism". This patent covers a broad set of claims regarding the integration of a diaphragm membrane into a rigid body of a cartridge functioning as both a fluidic seal and cover of the cartridge, and as a valve mechanism for fluidics control within the cartridge.

16 Nov 2009

Priority Review of the NDA for intravenous acetaminophen extended by three months

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its Priority Review of the New Drug Application (NDA) for intravenous (IV) acetaminophen by three months.

15 Nov 2009

Pro-Pharmaceuticals announces financial results for the third quarter and first nine months of fiscal 2009

Pro-Pharmaceuticals, Inc., a developer of galectin-targeted, carbohydrate therapeutic compounds to treat cancer and fibrosis, today reported its financial results for the third quarter and first nine months of fiscal 2009. These results are included in the Company’s Quarterly Report on Form 10-Q for the three- and nine-month periods ended September 30, 2009, which has been filed with the SEC.

13 Nov 2009

Agilent Technologies reports decreased revenues of $1.17 billion for the fourth fiscal quarter ended Oct. 31, 2009

Agilent Technologies Inc. today reported revenues of $1.17 billion for the fourth fiscal quarter ended Oct. 31, 2009, 21 percent below one year ago. Fourth quarter GAAP net income was $25 million, or $0.07 per diluted share. Last year’s fourth quarter GAAP net income was $231 million, or $0.64 per share.

13 Nov 2009

Emergent BioSolutions acquires 55,000 square foot manufacturing facility from MdBio Foundation

Emergent BioSolutions Inc. announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore for a total purchase price of $8.2 million. The facility, located within the City of Baltimore, Maryland, previously operated as a Food and Drug Administration (FDA) licensed facility used by an experienced contract manufacturing organization (CMO) to produce a number of FDA approved products.

13 Nov 2009

"Make Our Food Safe" coalition urges Senate to enact stronger food safety laws

Over the next several weeks, the U. S. Senate has an historic opportunity to take a major step toward improving food safety for all Americans. That is why a coalition of public health professionals, consumer organizations and groups representing victims of foodborne illness is sending the message that it is time to "Make Our Food Safe for the Holidays!"

13 Nov 2009

Majority of New Hampshire voters support food safety legislation

An overwhelming majority of New Hampshire voters - 90 percent - support food safety legislation that would give the Food and Drug Administration (FDA) new authority to ensure the food Americans eat does not make them sick, according to a new poll commissioned by the Pew Health Group and conducted by Hart Research and Public Opinion Strategies.

13 Nov 2009

Focus on healthy lifestyle to maintain weight this holiday season

Making sure you get right back on your weight loss plan after a big holiday meal is what will help you maintain your weight this holiday season.

13 Nov 2009

CSHL solves the structure of the zinc-bound ATD domain of the NMDA receptor NR2B subunit

A team of scientists at Cold Spring Harbor Laboratory (CSHL) reports on Thursday their success in solving the molecular structure of a key portion of a cellular receptor implicated in Alzheimer's, Parkinson's, and other serious illnesses.

13 Nov 2009

New knowledge of basic science may be applied in future medical treatments

How does the developing pancreas in an embryo 'know' which cells are to produce insulin and which cells are to have other assignments? Researchers need to understand this if they want to be able to treat type-1 diabetes with stem cells developed into insulin-producing beta cells. At Lund University scientists have uncovered pioneering new knowledge, and are publishing it in the journal Cell.

13 Nov 2009

Food News and Research

Alkermes' phase 3 trial of naltrexone XR-NTX meets primary endpoint

Sunlight Saunas renamed as Sunlighten

FDA issues a Complete Response Letter for Human Genome Sciences' raxibacumab BLA

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

A.P. Pharma announces financial results for its third quarter ended September 30, 2009

Fetal exposure to phthalates has the potential to alter masculine brain development: Study

FDA files for permanent injunction against seafood processor Haifa Smoked Fish

Ginger effective in treating post-chemo nausea in cancer patients

FDA provides marketing clearance for the Platelet PGD Test System

Potential success of U.N. World Food Summit questioned

Patent number for Microfluidic Valve Mechanism received

Priority Review of the NDA for intravenous acetaminophen extended by three months

Pro-Pharmaceuticals announces financial results for the third quarter and first nine months of fiscal 2009

Agilent Technologies reports decreased revenues of $1.17 billion for the fourth fiscal quarter ended Oct. 31, 2009

Emergent BioSolutions acquires 55,000 square foot manufacturing facility from MdBio Foundation

"Make Our Food Safe" coalition urges Senate to enact stronger food safety laws

Majority of New Hampshire voters support food safety legislation

Focus on healthy lifestyle to maintain weight this holiday season

CSHL solves the structure of the zinc-bound ATD domain of the NMDA receptor NR2B subunit

New knowledge of basic science may be applied in future medical treatments

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News